Glumetinib
Tier C — Watch / tradeGlumetinib
Targets：c-Met
Brand：Haiyitan
Indications (approved)：Non-small cell lung cancer
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| GLUME-001 | 1150617-54-1 | 6-bromo-1H-pyrazolo[4,3-b]pyridine |
| GLUME-002 | 761446-44-0Available | 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole |
| GLUME-003 | 1642583-00-3 | 6-(1-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,3-b]pyridine |
| GLUME-004 | 1642583-16-1 | 6-chloroimidazo[1,2-a]pyridine-3-sulfonyl chloride |
| GLUME-005 | 1642581-60-9 | 1-((6-chloroimidazo[1,2-a]pyridin-3-yl)sulfonyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,3-b]pyridine |
| Glumetinib | 1642581-63-2 | - |
Frequently asked questions
What are the approved indications of Glumetinib?
Approved indications include: Non-small cell lung cancer.
When does the Glumetinib patent expire?
No public expiry year is available for Glumetinib yet; this page updates once verified.
How many synthesis routes are recorded for Glumetinib?
1 synthesis routes are recorded; the shortest is 3 steps with 23 mg (Glumetinib) total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Glumetinib intermediates?
1 intermediate CAS of Glumetinib are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Glumetinib intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29